RecruitingPhase 3NCT05710198

Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma

Studying Familial LCAT deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Omikron Italia S.r.l.
Intervention
Citicoline eye drops 2%(drug)
Enrollment
1000 target
Eligibility
18 years · All sexes
Timeline
20232027

Study locations (1)

Collaborators

OPIS Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05710198 on ClinicalTrials.gov

Other trials for Familial LCAT deficiency

Additional recruiting or active studies for the same condition.

See all trials for Familial LCAT deficiency

← Back to all trials